The mediator and cellular basis of the allergic response

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.

ESMO open·2026

Understanding first-line treatment patterns and survival outcomes across sociodemographic groups of women with metastatic triple-negative breast cancer in the United States: a real-world study.

ESMO open·2025

[Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2025

Effectiveness of sacituzumab govitecan and management of neutropenia in patients with metastatic triple-negative breast cancer treated in real-world settings in the United States.

ESMO open·2025

The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study.

ESMO open·2025

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies.

ESMO open·2025

Epithelial AhR-NKX3-1-Senescence Axis Drives Barrier Function and Inflammation in Allergic Rhinitis.

Allergy·2026

Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non-Irritative Concentrations.

Allergy·2026

Placental Epigenetic Alterations and IL-10 Dysregulation Drive Early Persistent Food Allergy.

Allergy·2026

Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence-Based Medicine: Current Aspects 2026.

Allergy·2026

Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper.

Allergy·2026

Pathogenic Airway Bacteria and Local Immune Responses During Early-Life Asthma-Like Episodes.

Allergy·2026

Real-World Concordance of Indirect Immunofluorescence and Antigen-Specific Assays in Antineutrophil Cytoplasmic Antibody Testing: A Retrospective High-Volume Laboratory Study.

The Eurasian journal of medicine·2026

Pulmonary Delivery of Silk Fibroin Peptides Dry Powder Inhalers for Idiopathic Pulmonary Fibrosis.

Journal of drug targeting·2026

Relentless Placoid Chorioretinitis in a Patient with Atopic Dermatitis Treated with Dupilumab.

Ocular immunology and inflammation·2026

Benralizumab in bronchiectasis: results from the phase 3 MAHALE study.

ERJ open research·2026

Case Report: Sequential eculizumab and belimumab in a paediatric patient with lupus nephritis and immune complex-mediated renal microangiopathy.

Frontiers in immunology·2026

Related Experiment Videos

The mediator and cellular basis of the allergic response

Related Concept Videos

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.

Understanding first-line treatment patterns and survival outcomes across sociodemographic groups of women with metastatic triple-negative breast cancer in the United States: a real-world study.

[Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder].

Effectiveness of sacituzumab govitecan and management of neutropenia in patients with metastatic triple-negative breast cancer treated in real-world settings in the United States.

The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study.

First-in-human study of FAZ053, an anti-programmed death-ligand 1 (anti-PD-L1) monoclonal antibody, alone and in combination with spartalizumab (anti-PD-1), in patients with advanced malignancies.

Epithelial AhR-NKX3-1-Senescence Axis Drives Barrier Function and Inflammation in Allergic Rhinitis.

Updated EAACI Statement on Drug Hypersensitivity Skin Testing: Methodology and Non-Irritative Concentrations.

Placental Epigenetic Alterations and IL-10 Dysregulation Drive Early Persistent Food Allergy.

Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence-Based Medicine: Current Aspects 2026.

Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper.

Pathogenic Airway Bacteria and Local Immune Responses During Early-Life Asthma-Like Episodes.

Real-World Concordance of Indirect Immunofluorescence and Antigen-Specific Assays in Antineutrophil Cytoplasmic Antibody Testing: A Retrospective High-Volume Laboratory Study.

Pulmonary Delivery of Silk Fibroin Peptides Dry Powder Inhalers for Idiopathic Pulmonary Fibrosis.

Relentless Placoid Chorioretinitis in a Patient with Atopic Dermatitis Treated with Dupilumab.

Benralizumab in bronchiectasis: results from the phase 3 MAHALE study.

Case Report: Sequential eculizumab and belimumab in a paediatric patient with lupus nephritis and immune complex-mediated renal microangiopathy.

Related Experiment Videos

The mediator and cellular basis of the allergic response

Related Concept Videos

Related Articles